Lipiles 20 mg (Tablet)
Unit Price: ৳ 18.00 (1 x 10: ৳ 180.00)
Strip Price: ৳ 180.00
Medicine Details
Category | Details |
---|---|
Generic | Atorvastatin calcium |
Company | Pharmasia limited |
Also available as |
ProductTitle
Lipiles 20 mg Tablet
Categories
- Medicine
- Pharmaceuticals
- Cholesterol Management
Description
Lipiles 20 mg Tablet is a selective inhibitor of HMG-CoA reductase indicated as an adjunct to diet to reduce elevated cholesterol levels. It is used for the treatment of hypercholesterolaemia, dyslipidemia, and prevention of cardiovascular events.
Dimensions
- Tablet Size: 20 mg
ColorOptions
- White
Functions
- Reduces total cholesterol and LDL cholesterol levels
- Increases hepatic LDL receptors for enhanced uptake of LDL
- Lowers triglycerides and apolipoprotein B levels
Materials
- Active Ingredient: Atorvastatin
- Chemical Structure: C33H35FN2O5
TechnicalSpecifications
- Rapidly absorbed after oral administration
- Increases in absorption proportionate to dose
- Volume of distribution: approximately 381 liters
- Systemic availability of HMG-CoA reductase inhibitory activity: approximately 30%
- Metabolized by cytochrome P450 3A4
- Plasma elimination half-life: approximately 14 hours
DesignElements
- Selective inhibitor of HMG-CoA reductase
- Chemical structure
UsabilityFeatures
- Once daily administration
- Can be taken with or without food
- Recommended starting dose: 10 or 20 mg once daily
- Dosage range: 10 to 80 mg once daily
- Dosing adjustments based on lipid levels
- Indicated for adults and children (10-18 years)
- Can be taken for long-term use
Contraindications
- Hypersensitivity to any component of the medication
- Active liver disease
- Unexplained persistent elevations of serum transaminases
- History of serious adverse reaction to prior administration of HMG-CoA reductase inhibitors
SideEffects
- Constipation
- Flatulence
- Dyspepsia
- Abdominal pain
- Infection
- Headache
- Back pain
- Rash
- Asthenia
- Arthralgia
- Myalgia
PregnancyAndLactation
- Contraindicated during pregnancy
- Safety not established in pregnant women
- Not to be used by breastfeeding women
PrecautionsAndWarnings
- Liver function tests recommended before initiation of treatment
- Discontinue therapy if markedly elevated CPK levels occur or myopathy is diagnosed or suspected
SpecialPopulations
- Greater degree of LDL-lowering in elderly patients
- No pediatric pharmacokinetic data available
- No clinically significant gender difference in LDL-C reduction
- No influence of renal disease on plasma concentrations or LDL-C reduction
- Markedly increased plasma concentrations in patients with chronic alcoholic liver disease
OverdoseEffects
- Specific treatment not available
- Liver function tests and serum CK level monitoring recommended
TherapeuticClass
- Other Anti-anginal & Anti-ischaemic drugs
- Statins
StorageConditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children